1312590-07-0

Basic information

• Product Name: C₁₃H₁₅F₃O
• Synonyms: C₁₃H₁₅F₃O
• CAS NO: 1312590-07-0
• Molecular Weight: 244.257
• Mol File: 1312590-07-0.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: C₁₃H₁₅F₃O(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₃H₁₅F₃O(1312590-07-0)
• EPA Substance Registry System: C₁₃H₁₅F₃O(1312590-07-0)

Safety Data

• Hazardous Substances Data: 1312590-07-0(Hazardous Substances Data)

Upstream product

• 1224883-92-4 1-(4-trifluoromethylphenyl)-5-hexen-1-one 
• 25771-21-5 N,N-dimethyl 4-(trifluoromethyl)benzamide 
• 34164-50-6 4-penten-1-ylmagnesium bromide 
• 329-15-7 4-trifluoromethyl-phenyl acetyl chloride 

Downstream Products

• 1312590-08-1 C₁₃H₁₄F₃IO 
• 1312590-09-2 C₂₁H₁₈F₃NO₃ 
• 1312590-10-5 C₁₃H₁₆F₃NO 
• 1351865-00-3 C₁₉H₁₉F₃N₂O₃ 
• 1351864-99-7 C₂₀H₂₁F₃N₂O₃ 
• 1312781-38-6 C₂₁H₁₈F₃NO₃ 
• 1416328-86-3 C₃₁H₄₀F₃N₅O₄ 

Relevant articles and documents

NEW SELECTIVE CCR2 ANTAGONISTS

The present invention relates to novel and selective antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD as well as pain.

NEW SELECTIVE CCR2 ANTAGONISTS

The present invention relates to novel and selective antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD as well as pain.

NEW CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) of Formula (I) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.